BACKGROUND: We have previously shown the importance of mgrA and sarA in controlling autolysis of Staphylococcus aureus, with MgrA and SarA both being negative regulators of murein hydrolases. METHODS: In this study, we analyzed the effects of mgrA and sarA on antibiotic-mediated lysis in vitro and on the responses to cell wall-active antibiotic therapy in an experimental endocarditis model by use of 2 representative MRSA strains: the laboratory strain COL and the community-acquired clinical strain MW2. RESULTS: We found that mgrA and sarA independently down-regulated sarV (a marker for autolysis), although the alteration in sarV expression did not correlate directly with the autolysis profiles of single mgrA and sarA mutants. Importantly, the mgrA/sarA double mutants of both strains were more autolytic than the single mutants in vitro. We demonstrated that, despite equivalent intrinsic virulences of the parent strains and their isogenic mgrA/sarA double mutants in the endocarditis model, oxacillin and vancomycin treatment of the mgrA/sarA double mutants yielded significant reductions in vegetation bacterial densities in vivo, compared with treatment of their respective parent strains. CONCLUSIONS: These results suggest that down-regulation of mgrA/sarA in combination with use of cell wall-active antibiotics may represent a novel approach to treat MRSA infections.
BACKGROUND: We have previously shown the importance of mgrA and sarA in controlling autolysis of Staphylococcus aureus, with MgrA and SarA both being negative regulators of murein hydrolases. METHODS: In this study, we analyzed the effects of mgrA and sarA on antibiotic-mediated lysis in vitro and on the responses to cell wall-active antibiotic therapy in an experimental endocarditis model by use of 2 representative MRSA strains: the laboratory strain COL and the community-acquired clinical strain MW2. RESULTS: We found that mgrA and sarA independently down-regulated sarV (a marker for autolysis), although the alteration in sarV expression did not correlate directly with the autolysis profiles of single mgrA and sarA mutants. Importantly, the mgrA/sarA double mutants of both strains were more autolytic than the single mutants in vitro. We demonstrated that, despite equivalent intrinsic virulences of the parent strains and their isogenic mgrA/sarA double mutants in the endocarditis model, oxacillin and vancomycin treatment of the mgrA/sarA double mutants yielded significant reductions in vegetation bacterial densities in vivo, compared with treatment of their respective parent strains. CONCLUSIONS: These results suggest that down-regulation of mgrA/sarA in combination with use of cell wall-active antibiotics may represent a novel approach to treat MRSA infections.
Authors: Yingfang Liu; Adhar C Manna; Cheol-Ho Pan; Irina A Kriksunov; Daniel J Thiel; Ambrose L Cheung; Gongyi Zhang Journal: Proc Natl Acad Sci U S A Date: 2006-02-02 Impact factor: 11.205
Authors: Peng R Chen; Taeok Bae; Wade A Williams; Erica M Duguid; Phoebe A Rice; Olaf Schneewind; Chuan He Journal: Nat Chem Biol Date: 2006-09-17 Impact factor: 15.040
Authors: James E Cassat; Paul M Dunman; Fionnuala McAleese; Ellen Murphy; Steven J Projan; Mark S Smeltzer Journal: J Bacteriol Date: 2005-01 Impact factor: 3.490
Authors: Elizabeth A Shakhnovich; Deborah T Hung; Emily Pierson; Kyungae Lee; John J Mekalanos Journal: Proc Natl Acad Sci U S A Date: 2007-02-05 Impact factor: 11.205
Authors: Wessam Abdelhady; Arnold S Bayer; Kati Seidl; Derek E Moormeier; Kenneth W Bayles; Ambrose Cheung; Michael R Yeaman; Yan Q Xiong Journal: J Infect Dis Date: 2014-01-07 Impact factor: 5.226
Authors: Dario Lehoux; Arnold S Bayer; Sonia U Shah; Yan Q Xiong; Wessam Abdelhady; James Iwaz; Youngju Pak; Raymond Schuch; Cara Cassino Journal: Antimicrob Agents Chemother Date: 2020-06-23 Impact factor: 5.191
Authors: Anu Daniel; Chad Euler; Mattias Collin; Peter Chahales; Kenneth J Gorelick; Vincent A Fischetti Journal: Antimicrob Agents Chemother Date: 2010-01-19 Impact factor: 5.191